| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > The Magic of Marketing Momentum |
|
Just Other Articles - The Magic of Marketing Momentum
A very surprising thing happens just about every time I sit down to work on my marketing plan, call a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product prospective client, mail a few thank-you notes to current clients, or take any other marketing-related ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in action -- even if it’s just to conjure up some new marketing strategies. Whenever I have a true inten lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tion to market, the Universe responds by opening a door. A client I haven’t heard from in a while asks here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe me to do a big assignment. I find out that my pitch to a big company has paid off, and my contact is r d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro eady to sign a contract. Or I get an out-of-the-blue call that brings me glad tidings of great joy and ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc prosperity (that is, the caller has never talked to me before but knows about my work and implores me easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi with all sincerity to do a project in just two weeks, adding, of course, that the company will happily nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically give me 150 percent of my usual fee … all in advance!) That last scenario doesn’t happen very often and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ (well, okay, it happened just twice), but other “door openings” are very common. These door openings t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ll me that just having the intention to market is often enough to start or increase the flow of abunda ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nce in my life. I am rewarded for making the effort and being willing. However, I know I can’t fool m dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod yself, much less the Universe: My intention must be honest. It’s not enough to simply think about the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin fact that I need to do some marketing. I must intend to actually do some marketing very soon -- usuall tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen that day. In many cases my intention registers only after I put myself into marketing mode by doing s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ome definitive action, such as making a list of people who are due for follow ups, working on my web s ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ite or simply reading a book filled with marketing ideas that rev up my enthusiasm and creativity. The y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the doors of opportunity open. I call these door openings the “magic of marketing momentum,” but tha . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t doesn’t mean you can rely on magic alone. Intention is the key you must put into the lock. Action is elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the process of turning the key and opening the door. What’s inside? Opportunity and prosperity. Enjoy tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Corporate Promotional Gifts : The Fridge Magnet Is Dead, Long Live the Computer Desktop 10 Tips To Profit From A Resignation To Build Your Business, Appreciate the Customers You Already Have
|